[go: up one dir, main page]

DE60219957T8 - Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on - Google Patents

Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on Download PDF

Info

Publication number
DE60219957T8
DE60219957T8 DE60219957T DE60219957T DE60219957T8 DE 60219957 T8 DE60219957 T8 DE 60219957T8 DE 60219957 T DE60219957 T DE 60219957T DE 60219957 T DE60219957 T DE 60219957T DE 60219957 T8 DE60219957 T8 DE 60219957T8
Authority
DE
Germany
Prior art keywords
formula
sub
acid addition
preparation
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60219957T
Other languages
English (en)
Other versions
DE60219957D1 (de
DE60219957T2 (de
Inventor
Lászlo PONGO
Jozsef Reiter
Gyula Simig
Gábor Berecz
György CLEMENTIS
Peter Slegel
János SZULAGYI
Lászlo KONCZ
Györgyi VERECZKEYNE DONATH
Kálmán NAGY
Gyuláne KÖRTVELYESSY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Publication of DE60219957D1 publication Critical patent/DE60219957D1/de
Publication of DE60219957T2 publication Critical patent/DE60219957T2/de
Application granted granted Critical
Publication of DE60219957T8 publication Critical patent/DE60219957T8/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60219957T 2001-11-13 2002-11-13 Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on Active DE60219957T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0104873 2001-11-13
HU0104873A HU227118B1 (en) 2001-11-13 2001-11-13 Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
PCT/HU2002/000120 WO2003042212A1 (en) 2001-11-13 2002-11-13 Improved process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one

Publications (3)

Publication Number Publication Date
DE60219957D1 DE60219957D1 (de) 2007-06-14
DE60219957T2 DE60219957T2 (de) 2008-01-17
DE60219957T8 true DE60219957T8 (de) 2008-04-24

Family

ID=89979882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219957T Active DE60219957T8 (de) 2001-11-13 2002-11-13 Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on

Country Status (14)

Country Link
US (1) US7307168B2 (de)
EP (1) EP1461338B1 (de)
JP (1) JP4297785B2 (de)
AT (1) ATE361298T1 (de)
BG (1) BG108757A (de)
CZ (1) CZ2004698A3 (de)
DE (1) DE60219957T8 (de)
DK (1) DK1461338T3 (de)
ES (1) ES2286332T3 (de)
HU (1) HU227118B1 (de)
PL (1) PL369233A1 (de)
PT (1) PT1461338E (de)
SK (1) SK2542004A3 (de)
WO (1) WO2003042212A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009591A1 (en) * 2002-07-22 2004-01-29 Aurobindo Pharma Ltd. A process for the preparation of antipsychotic risperidone
AU2003288017A1 (en) 2002-11-13 2004-06-03 Synthon B.V. Process for making risperidone and intermediates therefor
HUP0401379A3 (en) * 2004-07-08 2006-04-28 Richter Gedeon Vegyeszet Process for the preparation of risperidon
HUP0402163A2 (en) * 2004-10-25 2006-05-29 Richter Gedeon Vegyeszet Process for the preparation of risperidone
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
CN112624992B (zh) * 2021-01-19 2026-01-02 浙江华海药业股份有限公司 一种6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
ES2085234B1 (es) * 1994-02-24 1997-01-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ATE264329T1 (de) * 2000-05-05 2004-04-15 Rpg Life Sciences Ltd Verfahren zur herstellung von antipsychotischem 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-

Also Published As

Publication number Publication date
CZ2004698A3 (cs) 2004-09-15
US7307168B2 (en) 2007-12-11
DE60219957D1 (de) 2007-06-14
HU0104873D0 (en) 2002-01-28
ATE361298T1 (de) 2007-05-15
EP1461338A1 (de) 2004-09-29
HU227118B1 (en) 2010-07-28
HUP0104873A3 (en) 2003-11-28
US20050004141A1 (en) 2005-01-06
BG108757A (bg) 2005-03-31
DK1461338T3 (da) 2007-09-03
DE60219957T2 (de) 2008-01-17
JP4297785B2 (ja) 2009-07-15
ES2286332T3 (es) 2007-12-01
SK2542004A3 (en) 2004-12-01
EP1461338B1 (de) 2007-05-02
HUP0104873A2 (hu) 2003-08-28
WO2003042212A1 (en) 2003-05-22
PL369233A1 (en) 2005-04-18
PT1461338E (pt) 2007-07-23
JP2005513019A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
JP6598974B2 (ja) B型肝炎ウイルス感染症の治療および予防のための新規な三環式4−ピリドン−3−カルボン酸誘導体
AU2010294292B2 (en) Sulfonamides as inhibitors of Bcl-2 family proteins for the treatment of cancer
US7601833B2 (en) Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
US20060004003A1 (en) Pyrazolopyridine derivatives
NO2007017I2 (no) 3-[2-[4-(6-fluor-1,2-benzoksazol-3-yl)-1-piperidinyl]etyl]-6,7,8,9-tetrahydro-9-hydroksy-2-metyl-4H-pyridol]1,2-a]pyrimidin-4-on(palperidone)
JPH01500834A (ja) アザインドール及びインドリジン誘導体、その製造方法及び薬剤としてのその用途
DE60219957T8 (de) Verbessertes verfahren zur herstellung von 3-(2-(4-(6-fluor-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-on
US7977480B2 (en) Synthesis of paliperidone
EP1214321B1 (de) Herstellungsverfahren für derivate der naphthyridin-3-carbonsäure
JPH09500143A (ja) 新規キノロンカルボン酸誘導体
EP2138490B1 (de) Neues Syntheseverfahren für Fluorquinolone
RU95101859A (ru) СПОСОБ ПОЛУЧЕНИЯ 3-{(2-[4-(6-ФТОРБЕНЗО[d]ИЗОКСАЗОЛ-3-ИЛ)ПИПЕРИДИН-1-ИЛ]ЭТИЛ})-2-МЕТИЛ-6,7,8,9-ТЕТРАГИДРО-4Н-ПИРИДО[1,2-a]ПИРИМИДИН-4-ОНА И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ ДЛЯ ЕГО ПОЛУЧЕНИЯ
CA1323876C (en) Dihydropyridine derivatives and pharmaceutical composition thereof
US7423152B2 (en) Process for the manufacture of intermediates in camptothecin production
JP2003183283A (ja) 縮合インドール化合物、その製造法および用途
KR0153530B1 (ko) 락탐 유도체의 제조 방법
ATE336482T1 (de) Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung
WO2002024696A1 (en) Process for producing tricyclic fused heterocyclic derivative
CN1255411C (zh) 苯并氧硫杂䓬并[3,4-b]吡啶衍生物、其制备方法及其作为药物的用途
KR100376774B1 (ko) 피페리딘 유도체 및 약학적으로 허용가능한 그것의 염의제조방법
HU194170B (en) Process for production of derivatives of dihydropiridin with positive inotrop influence and medical compounds containing thereof
JP2002167386A (ja) 3環式縮合複素環誘導体の製造法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1461338

Country of ref document: EP

Representative=s name: STOLMAR & PARTNER, DE